Andrew Gottesdiener
CIK: 0001972292
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Gottesdiener Andrew
Gottesdiener Andrew (SEC CIK 0001972292) files insider reports with the SEC as Director of Korsana Biosciences, Inc. (KRSA) and Director of Apogee Therapeutics, Inc. (APGE).
Signal8 holds 3 ownership filings by Gottesdiener Andrew (1 Form 3, 2 Form 4), filed between Jun 20, 2025 and Sep 10, 2026. Those filings report 2 transactions, from Jun 17, 2025 to Sep 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Gottesdiener Andrew's filings is in WALTHAM, MA.
Recent filings by Gottesdiener Andrew
Other insiders filing for Korsana Biosciences, Inc. (KRSA)
- Pernice Michelle Patricia, Director
- Shah Nimish P, Director
- Fairmount Funds Management LLC, Director
- Violin Jonathan
- Leoni Matthew James, Chief Medical Officer
- HENSON HEIDI, Director